The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
R

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal Cell Carcinoma

By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
178 views
August 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das
Genitourinary
11:59

KU ASCO GU 2019 Updates: Enzalutamide vs. Apalutamide in Metastatic …

KU Hematology & Medical Oncology Review 2019

R. Parikh

847 views
11:41

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal…

KU Hematology & Medical Oncology Review 2019

R. Parikh

178 views